
Georgia Tech researchers received a $1.6 million grant from the NIH and NINDS for neuroscience project
On Aug. 21, 2019, Georgia Institute of Technology researchers Chris Rozell and Garret Stanley received a $1.6 million grant from the National Institutes of Health (NIH) and NINDS (National Institutes of Neurological Disorders and Stroke) for a neuroscience project to develop intelligent algorithms for interacting with the brain.
“Intelligent algorithms for interacting with the brain holds promise to help us alleviate diseases with no current treatments, as well as better understanding the basis of human intelligence,” says Chris Rozell, professor in Georgia Tech’s School of Electrical and Computer Engineering, who is leading the study with Garrett Stanley, professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Both are researchers in the the Petit Institute for Bioengineering and Bioscience at Georgia Tech, where Rozell also is a member of the Center for Machine Learning and Stanley is co-director of the Neural Engineering Center?
The five-year project, called “Closed-Loop Computational Neuroscience for Causally Dissecting Circuits,” will build on the theory, methods, and findings of engineering, computer science, neuroscience, and other disciplines (machine learning and genetics, for example). Through the CRCNS program, the National Science Foundation and National Institutes of Health (along with several international partners) support collaborative activities designed to advance understanding of nervous system structure and function, the mechanisms underlying nervous system disorders, and the computational strategies used by the nervous system.
“The advances in tools that we and others have made in precisely measuring and manipulating neurons and neural circuits now make it possible to read and write brain activity at the same time, and communicate with the brain in the fast timescale on which it operates,” says Stanley, professor in the Wallace H. Coulter Department of Biomedical Engineering. “We think this is a game-changer, experimentally and computationally.”
Many disorders such as Parkinson’s disease, Alzheimers, depression and epilepsy are due to some dysfunction that disrupts normal activity in certain neural circuits. We currently have no cures for any of these disorders, only medications to slow them or manage symptoms. Long term, many people believe that we may be able to use implants to stimulate the circuits and directly correct the activity that has gone wrong. To achieve that goal, we must have the types of intelligent adaptive algorithms for interacting with circuits in the brain that we will pioneer in this project. In the short term these tools will help us better understand normal and disordered brain function, but eventually they could form the basis of novel therapies that correct neurologic deficits without medications.
Tags:
Source: Georgia Tech
Credit:
